Annual Revenue ($)

Medtronic revenue was $29.95 b in FY, 2018 which is a 0.8% year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018
Revenue$17.01 b$20.26 b$28.83 b$29.71 b$29.95 b
Growth19.15%42.31%3.04%0.82%
Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019
Revenue$0$7.27 b$7.06 b$6.93 b$7.17 b$7.35 b$7.28 b$7.39 b$7.05 b$21.81 b$7.38 b$7.48 b
Report incorrect company information

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Medtronic revenue breakdown by business segment: 7.1% from Diabetes Group, 25.9% from Restorative Therapies Group, 37.9% from Cardiac and Vascular Group and 29.1% from Minimally Invasive Therapies Group

Medtronic revenue breakdown by geographic segment: 46.7% from Rest of World, 53.0% from United States and 0.3% from Other

FY, 2016FY, 2017FY, 2018
Diabetes Group1.86 b1.93 b2.14 b
Restorative Therapies Group7.21 b7.37 b7.74 b
Cardiac and Vascular Group 10.20 b10.50 b11.35 b
Minimally Invasive Therapies Group9.56 b9.92 b8.72 b
FY, 2016FY, 2017FY, 2018
Rest of World12.33 b12.98 b13.99 b
Ireland 79 m69 m85 m
United States16.42 b16.66 b15.88 b
Report incorrect company information